Please view our presentation at the 19th Annual Rodman & Renshaw Global Investment Conference
Ross Macdonald tells CNBC about how the company has progressed to a phase 1 clinical trial
Q&A between Cynata CEO Dr Ross Macdonald and the respected and influential industry commentator Professor Paul Knoepfler of the UC Davis School of Medicine
A brief presentation on recent activities at Cynata
Please listen to an interview with Dr Adrian Bloor, UK Chief Investigator in Cynata’s Phase 1 clinical trial in acute steroid resistant graft-versus-host disease (GvHD).